Breaking News

Spinnovation To Provide Analytical Services at Pivot Park

March 11, 2013

Gains access to advanced facilities and instrumentation

Spinnovation Analytical BV and Pivot Park have entered an agreement under which Spinnovation will supply analytical services at the newly established life sciences park, and will gain access to Pivot Park’s advanced analytical platform. Pivot Park, located on the former Organon/Schering Plough/MSD research site in Oss, the Netherlands, is a center for open innovation, where the facilities and instrumentation are made available to pharma and biopharma companies.
Spinnovation will support the park’s research and productivity with its portfolio of analytical services for both small-molecule pharmaceuticals and biopharmaceuticals. The agreement allows Spinnovation to expand its technology platform with exclusive access to several high-end analytical instruments.
Spinnovation will cover the analytical needs of medicinal chemists focused on discovery programs and preclinical development, as well as CMOs, by supporting CMC activities. Spinnovation will add to the platform at Pivot Park by providing 500MHz NMR, ESI-TOF MS, HPLCs, LC-SPE and ICP-OES instruments. The facilities at Pivot Park will also help Spinnovation develop Spinnovation Biologics, a service dedicated to the support of upstream process development for the production of biotherapeutics.
“We are very excited to welcome Spinnovation who will facilitate access to advanced analytical applications for the Pivot Park tenants,” said Alie Tigchelhoff, director of Pivot Park. “We have full confidence that Spinnovation’s exceptional analytical solutions will support the growth of our companies and the spirit of research and development which the park has been designed for.”
blog comments powered by Disqus
  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • A Case for One Assay Analysis of PK and Immunogenicity in Biosimilar Research

    A Case for One Assay Analysis of PK and Immunogenicity in Biosimilar Research

    Stephanie Mowery, Sherri Rinker, Franklin Spriggs and Bo Kowalcyk , AIT Bioscience||June 2, 2015
    Moving forward clinical studies will have to include a comparative assessment of pharmacokinetics and immunogenicity to the original reference biologic drug